Duality Advisers’s Axonics, Inc. Common Stock AXNX Stock Holding History

Duality Advisers’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29,367	Closed	-$1.48M	–	750
2023 Q2	$1.48M	Sell	29,367 -72	-0.2%	-$3.83K	0.19%	212
2023 Q1	$1.61M	Buy	29,439 +640	+2%	+$37.4K	0.18%	210
2022 Q4	$1.8M	Buy	28,799 +2,524	+10%	+$167K	0.2%	178
2022 Q3	$1.85M	Buy	+26,275	New	+$1.81M	0.2%	198

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Duality Advisers's AXNX Position: Q3 2023 in Review

Duality Advisers sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 29,367 shares — an estimated $1.48M sold.

Duality Advisers first reported a position in AXNX in Q3 2022 and held it in 4 quarters. The position peaked at $1.85M in Q3 2022. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

Duality Advisers reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Duality Advisers sold 29,367 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $1.48M.
Duality Advisers first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Duality Advisers's Axonics, Inc. Common Stock position peaked at $1.85M in Q3 2022.
220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.